| Literature DB >> 34294860 |
Dejene Kebede1,2, Wende Mengesha3, Abebe Menkir4, Ayodeji Abe2, Ana Luisa Garcia-Oliveira5, Melaku Gedil4.
Abstract
Most of the maize (Zea mays L.) varieties in developing countries have low content of micronutrients including vitamin A. As a result, people who are largely dependent on cereal-based diets suffer from health challenges due to micronutrient deficiencies. Marker assisted recurrent selection (MARS), which increases the frequency of favorable alleles with advances in selection cycle, could be used to enhance the provitamin A (PVA) content of maize. This study was carried out to determine changes in levels of PVA carotenoids and genetic diversity in two maize synthetics that were subjected to two cycles of MARS. The two populations, known as HGA and HGB, and their advanced selection cycles (C1 and C2) were evaluated at Ibadan in Nigeria. Selection increased the concentrations of β-carotene, PVA and total carotenoids across cycles in HGA, while in HGB only α-carotene increased with advances in selection cycle. β-cryptoxanthine increased at C1 but decreased at C2 in HGB. The levels of β-carotene, PVA, and total carotenoids increased by 40%, 30% and 36% respectively, in HGA after two cycles of selection. α-carotene and β-cryptoxanthine content improved by 20% and 5%, respectively after two cycles of selection in HGB. MARS caused changes in genetic diversity over selection cycles. Number of effective alleles and observed heterozygosity decreased with selection cycles, while expected heterozygosity increased at C1 and decreased at C2 in HGA. In HGB, number of effective alleles, observed and expected heterozygosity increased at C1 and decreased at C2. In both populations, fixation index increased after two cycle of selections. The greatest part of the genetic variability resides within the population accounting for 86% of the total genetic variance. In general, MARS effectively improved PVA carotenoid content. However, genetic diversity in the two synthetics declined after two cycles of selection.Entities:
Year: 2021 PMID: 34294860 PMCID: PMC8298388 DOI: 10.1038/s41598-021-94586-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Number of plants (with favorable allels) and ears selected for each synthetic per cycle.
| Total number of plants selfed and genotyped in each cycle | Selected plants carrying favorable alleles | Number of ears selected and recombined | |||
|---|---|---|---|---|---|
| C1 | C2 | C1 | C2 | ||
| HGA | 288 | 60 | 193 | 50 | 151 |
| HGB | 288 | 197 | 165 | 52 | 126 |
Mean squares from analysis of variance for pro-vitamin A and other carotenoids of HGA and HGB populations improved through marker assisted recurrent selection.
| Source of variation | DF | Mean squares of carotenoids | ||||||
|---|---|---|---|---|---|---|---|---|
| Lutein (µg g−1) | Zeaxanthine (µg g−1) | β-cryptoxanthine (µg g−1) | a-carotene (µg g−1) | β-carotene (µg g−1) | provitamin A (µg g−1) | Total carotenoid (µg g−1) | ||
| Run | 1 | 0.021 | 0.001 | 0.0001 | 0.005 | 0.01 | 0.02 | 0.002 |
| Rep (Run) | 4 | 5.9 | 4.2 | 1.6** | 0.2* | 9.1 | 9.7 | 92.1** |
| Cycle | 5 | 196.5*** | 4.7*** | 0.6*** | 0.05* | 56.5*** | 51.6*** | 350.7*** |
| Run*Cycle | 5 | 0.003 | 0.002 | 0.0004 | 0.009 | 0.06 | 0.083 | 0.12 |
| Error | 20 | 3.4 | 2.5 | 0.3 | 0.05 | 7.1 | 6.1 | 21.7 |
*, **, *** = Significant at P < 0.05, P < 0.01, and P < 0.001, respectively.
Means and genetic gains for PVA and other carotenoids of HGA and HGB and their derived cycles improved through marker assisted recurrent selection.
| Cycle | Lutein (µg g−1) | Zeaxanthine (µg g−1) | Β-cryptoxanthine (µg g−1) | a-carotene (µg g−1) | β-carotene (µg g−1) | PVA (µg g−1) | Total carotenoid (µg g−1) |
|---|---|---|---|---|---|---|---|
| HGAC0 | 11.3 | 12.7 | 4.6 | 1.1 | 13.7 | 16.5 | 43.3 |
| HGAC1 | 10.5 | 11.0 | 4.7 | 1.0 | 14.0 | 16.8 | 41.2 |
| HGAC2 | 23.6 | 11.2 | 3.9 | 1.2 | 18.9 | 21.5 | 58.8 |
| HGBC0 | 22.3 | 11.7 | 4.2 | 1.0 | 19.3 | 21.9 | 58.4 |
| HGBC1 | 13.1 | 13.3 | 4.7 | 1.1 | 12.0 | 14.9 | 44.2 |
| HGBC2 | 18.8 | 11.4 | 4.4 | 1.2 | 17.6 | 20.4 | 53.4 |
| Mean | 16.6 | 11.9 | 4.4 | 1.1 | 15.9 | 18.7 | 49.9 |
| Gain cycle−1 HGA | 6.2 | − 0.7 | − 0.4 | 0.04 | 2.6 | 2.5 | 7.8 |
| % Resp cycle−1 HGA | 69.7 | − 5.8 | − 7.5 | 3.9 | 20.3 | 15.6 | 19.4 |
| Gain cycle−1 HGB | − 1.7 | − 0.1 | 0.1 | 0.1 | − 0.9 | − 0.8 | -2.5 |
| % Resp cycle−1 HGB | − 8.8 | − 1.1 | 2.2 | 11.1 | − 5 | − 3.8 | -4.6 |
| Repeatability | 0.99 | 0.58 | 0.64 | 0.10 | 0.90 | 0.91 | 0.96 |
| CV | 11 | 13 | 12 | 21 | 17 | 13 | 7.1 |
| LSD(0.05) | 1.9 | ns | ns | ns | 2.8 | 2.6 | 6.4 |
Resp response, ns non-significant.
Figure 1Allele frequency changes of crtRB1-KASP specific PVA marker alleles in HGA and its derived cycles. *The favorable alleles are bolded and underlined.
Figure 2Allele frequency changes of crtRB1-KASP specific PVA marker alleles in HGB and its derived cycles. *The favorable alleles are bolded and underlined.
Genetic variability based on SNP markers computed for HGA and its selection cycles.
| Cycles | # Samples 1 | Missing data (%)2 | % Polymorphic loci3 | # Effective alleles4 | Observed hetrozygosity5 | Expected hetrozygosity6 | Fixation Index7 |
|---|---|---|---|---|---|---|---|
| HGAC0 | 60 | 4.6 | 93 | 1.6 ± 0.026 | 0.33 ± 0.015 | 0.32 ± 0.014 | 0.01 ± 0.018 |
| HGAC1 | 60 | 3.9 | 94 | 1.6 ± 0.027 | 0.29 ± 0.013 | 0.33 ± 0.013 | 0.11 ± 0.019 |
| HGAC2 | 60 | 5.5 | 93 | 1.5 ± 0.027 | 0.24 ± 0.013 | 0.27 ± 0.013 | 0.13 ± 0.022 |
| Mean | 60 | 4.7 | 93 | 1.5 ± 0.016 | 0.29 ± 0.008 | 0.31 ± 0.008 | 0.08 ± 0.012 |
1# Number of samples correspond to number of plants from which leaf tissue was assayed.
2Percent (%) of missing data is the percentage of markers that did not return data computed per cycle.
3Percent of polymorphic loci is the percentage of polymorphic loci to the total number of loci (polymorphic and monomorphic) per cycle.
4Number of effective alleles are the number of alleles that can be present in the population.
5Observed heterozygosity is the number of markers within a population that are heterozygous calculated per cycle based.
6Expected heterozygosity is the probability that at a single locus, any two alleles chosen at random from the population are different to each other.
7Fixation index is the measure of reduction in heterozygosity.
Genetic variability based on SNP markers computed for HGB and its selection cycles.
| Cycles | # Samples1 | Missing data (%)2 | % Polymorphic loci3 | # Effective alleles4 | Observed hetrozygosity5 | Expected hetrozygosity6 | Fixation Index7 |
|---|---|---|---|---|---|---|---|
| HGBC0 | 60 | 3.7 | 88.6 | 1.5 ± 0.027 | 0.25 ± 0.015 | 0.27 ± 0.014 | 0.081 ± 0.02 |
| HGBC1 | 60 | 6.7 | 93.4 | 1.6 ± 0.027 | 0.3 ± 0.014 | 0.32 ± 0.013 | 0.054 ± 0.01 |
| HGBC2 | 60 | 5.8 | 94.6 | 1.5 ± 0.026 | 0.26 ± 0.014 | 0.29 ± 0.013 | 0.083 ± 0.021 |
| Mean | 60 | 5.4 | 92.2 | 1.5 ± 0.016 | 0.27 ± 0.008 | 0.29 ± 0.008 | 0.07 ± 0.011 |
1# Number of samples correspond to number of plants from which leaf tissue was assayed.
2Percent (%) of missing data is the percentage of markers that did not return data computed per cycle.
3Percent of polymorphic loci is the percentage of polymorphic loci to the total number of loci (polymorphic and monomorphic) per cycle.
4Number of effective alleles are the number of alleles that can be present in the population.
5Observed heterozygosity is the number of markers within a population that are heterozygous calculated per cycle based.
6Expected heterozygosity is the probability that at a single locus, any two alleles chosen at random from the population are different to each other.
7Fixation index is the measure of reduction in heterozygosity.
Figure 3Distribution of the different carotenoids across the S4 inbred lines derived from HGA.
Figure 4Distribution of the different carotenoids across the S4 inbred lines derived from HGB.